Screener
MiMedx Group MDXG Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by MiMedx Group in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001376339-26-000071
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | $64,995 | $86,105 |
| Stockholders' equity | ||
| Common stock; $0.001 par value; 250,000,000 shares authorized; 149,188,840 issued and 145,724,441 outstanding at June 30, 2026 and 148,093,920 issued and outstanding at December 31, 2025 | 149 | 148 |
| Additional paid-in capital | 297,094 | 299,081 |
| Treasury stock at cost; 3,464,399 shares at June 30, 2026 and 0 shares at December 31, 2025 | (12,859) | — |
| Accumulated deficit | (68,381) | (42,681) |
| Total stockholders' equity | 216,003 | 256,548 |
| Total liabilities and stockholders’ equity | $280,998 | $342,653 |
Item 1. Financial Statements
FAQ
- What is MiMedx Group's treasury stock?
- MiMedx Group (MDXG) reported treasury stock of $12.86M in Q2 2026.
- What is the long-term trend for MiMedx Group's treasury stock?
- Over 3 years (2020 to 2025), MiMedx Group's treasury stock has grown at a -100.0% compound annual growth rate (CAGR), from $7.45M to $0.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.
Ask your AI about MiMedx Group's treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude